Pfizer vax linked to woman’s blood clots: overseas case
The 59-year-old Omani woman developed thromboembolism that was thought to be heparin-induced thrombocytopenia within days of her first dose, with no other risk factors identified, say her doctors
Doctors have highlighted a possible link between the Pfizer-BioNTech COVID-19 vaccine and blood clots, after a woman developed what was thought to be heparin-induced thrombocytopenia (HIT) after her first dose.
The 59-year-old presented to the ED with a three-day history of sudden-onset leg pain one week after she was vaccinated, report doctors from Sultan Qaboos University Hospital in Muscat, Oman.
She had no history of trauma, immobilisation, surgery, weight loss or rash, they said.
Her medical history included type 2 diabetes treated with metformin, osteoarthritis and COVID-19 infection seven months’ earlier requiring one week’s hospitalisation on the general ward.
